⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.42
−0.29%
FTSE ADX
9,861.02
+0.80%
TASI
10,001.84
−1.20%
QE Index
8,575.87
−0.66%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,999.31
+0.02%
DFM:EMIRATESNBD
AED 31.48
−0.06%
ADX:IHC
AED 360.20
+2.33%
SAU:2222
SAR 25.76
−0.16%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.50
+0.34%
Gold
$4,124.90
−0.38%
Brent
$110.50
+1.17%
BTC
$81,466.43
−0.46%
ETH
$2,387.67
−0.73%
DFM General
5,834.42
−0.29%
FTSE ADX
9,861.02
+0.80%
TASI
10,001.84
−1.20%
QE Index
8,575.87
−0.66%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,999.31
+0.02%
DFM:EMIRATESNBD
AED 31.48
−0.06%
ADX:IHC
AED 360.20
+2.33%
SAU:2222
SAR 25.76
−0.16%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.50
+0.34%
Gold
$4,124.90
−0.38%
Brent
$110.50
+1.17%
BTC
$81,466.43
−0.46%
ETH
$2,387.67
−0.73%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Amgen Inc · News · TradingHolo
Markets
›
United States
› NAS
› AMGN
A
Amgen Inc
NAS:AMGN
Healthcare
CBOE:SPESG
DJ:DJA
$424.94
−1.75%
At close
At close · Tue 20 Oct · ≈
AED 1,560.59
· Market cap
$229.74B
· Next earnings
Tue 3 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
AMGN news
Headlines tagged to this company
SE
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
Seeking Alpha · 18 d ago
SE
Pharmaceutical industry lobbying group names new CEO, Eric Cantor
Seeking Alpha · 20 d ago
RE
Weight-loss drug developers line up to tap lucrative market as competition heats up
Reuters · 20 d ago
DO
Amgen Price Target Raised to $500.00/Share From $450.00 by Scotiabank
Dow Jones Newswires · 21 d ago
TR
Scotiabank maintains Sector Outperform rating on Amgen, $500 price target
TradingView · 21 d ago
TR
Weekly Recap: OASIZ‑301 dazodalibep meets ESSDAI and Topline lacks detail
TradingView · 22 d ago
GU
Amgen Gains as Sjogren's Drug Clears Phase 3
gurufocus · 26 d ago
SE
FDA commissioner nominee Overton rebuffs questions about Trump medical claims
seekingalpha · 26 d ago
SE
Veeva Systems gains new top 20 biopharma win for Vault CRM
seekingalpha · 27 d ago
ZA
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study
zacks · 27 d ago
ST
AMGN Jumps After Win In Sjögren’s Disease Trial As Citi Flags ‘Open Questions’
stocktwits · 28 d ago
BE
Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data
benzinga · 28 d ago
SE
Amgen gains on late-stage trial win for Sjögren's disease therapy
seekingalpha · 28 d ago
ZA
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
zacks · 29 d ago
SE
Healthcare stocks with the strongest dividend growth grades
seekingalpha · 29 d ago
SE
Trump administration is said to weigh allowing most pharma licensing deals with China
seekingalpha · 32 d ago
SE
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
seekingalpha · 33 d ago
SE
Alvotech wins double upgrade at Barclays on upcoming FDA decision
seekingalpha · 34 d ago
SE
FDA launches pilot program that aims to speed the time to first-in-human drug trials
seekingalpha · 35 d ago
SE
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
seekingalpha · 37 d ago
← Previous
More news →